The Baker Institute is committed to scientific excellence and our 2024 Best of Baker Awards recognise outstanding research achievement based on scientific publications. They demonstrate areas where scientific discoveries are likely to have a significant impact in health and medical research.
Our focus now is on translating this research to develop new drugs and devices, to inform policy, to develop best-practice prevention and treatment guidelines, and to facilitate education programs for healthcare professionals.
This is how our research is making a difference to the health of Australians and people around the world.
There were thirteen impressive Best of Baker papers. Our award winners were deemed the top papers in the three categories — Basic Science, Clinical/Epidemiology and Review.
Winners
- A lipid atlas of human and mouse immune cells provides insights into ferroptosis susceptibility (Basic Science)
- Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium (Clinical/Epidemiology)
- The influence of metabolic disorders on adaptive immunity (Review)
Runners up
- Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and Inflammation (Basic Science)
- Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation with or without left atrial posterior wall isolation: long-term outcomes of the CAPLA trial (Clinical/Epidemiology)
Other awardees
Basic Science
- EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors
- Imputation of plasma lipid species to facilitate integration of lipidomic datasets
- Integration of polygenic and gut metagenomic risk prediction for common diseases
- Piezo1 expression in neutrophils regulates shear-induced NETosis
Clinical/Epidemiology
- Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial
- Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilisation
- Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention
- Enhancing the Polygenic Score Catalog with tools for score calculation and ancestry normalization
